Home › Essential Thrombocythemia › Maryland › Baltimore
Essential Thrombocythemia clinical trials in Baltimore, MD
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Johns Hopkins Medicine-the Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Johns Hopkins University, Baltimore
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- John Hopkins Hospital, Baltimore
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Salt Lake City, UT4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Nashville, TN4 studies
- Mountain View, CA4 studies
- Cleveland, OH3 studies
- Houston, TX3 studies
- St. Louis, MO3 studies
- Los Angeles, CA3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.